Elevance Health Down 7% On Lower Q2 Profit
(RTTNews) - Elevance Health Inc. (ELV) shares are sliding more than 7 percent on Wednesday morning trade after the company reported a decline in second-quarter earnings.
Net income for the quarter declined 8.4 percent to $1.65 billion from $1.80 billion last year. Earnings per declined to 243.4 compared to 247.4 a year ago.
Currently, shares are at $464.75, down 6.57 percent from the previous close of $497.43 on a volume of 284,643. For the 52-week period, the shares have traded in a range of $355.43-$533.68 on average volume of 1,111,637.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.